Gilbert syndrome associated with beta-thalassemia

Pediatr Hematol Oncol. 2001 Dec;18(8):477-84. doi: 10.1080/088800101753328439.

Abstract

The authors investigated whether the considerable variability in serum bilirubin levels (STB) found in transfusion-dependent beta-thalassemia, beta-thal intermedia, and heterozygous beta-thalassemia individuals could be related to the coexistence of Gilbert syndrome (GS). The promoter region [A(TA)nTAA] of the bilirubin UDP-glucuronosyltransferase gene (UGT1A1) was analyzed in a total of 128 beta-thalassemia individuals (108 transfusion-dependent beta-thal patients, 20 very mild beta-thal intermedia) and in 33 beta-thal heterozygotes. The control group consisted of 70 healthy children with no history of anemia. The frequency of GS genotype (TA)7/(TA)7 did not differ significantly between the groups studied. A significant difference was observed between serum bilirubin levels (STB) and GS genotypes (TA)7/(TA)7 and (TA)6/(TA)7 and also between (TA)7/(TA)7 and (TA)6/(TA)6 for all groups examined. These results confirm that the (TA)7/(TA)7 GS genotype is one of the factors accounting for the hyperbilirubinemia observed in beta-thalassemia major, intermedia, and heterozygous individuals.

MeSH terms

  • Bilirubin / blood
  • Case-Control Studies
  • DNA Mutational Analysis
  • Genetic Testing
  • Genotype
  • Gilbert Disease / complications
  • Gilbert Disease / diagnosis*
  • Gilbert Disease / genetics
  • Glucuronosyltransferase / genetics
  • Greece / epidemiology
  • Promoter Regions, Genetic / genetics
  • beta-Thalassemia / complications*

Substances

  • Glucuronosyltransferase
  • Bilirubin